Zocor (simvastatin): increased risk of muscle injury with high doses

Zocor: Ongoing review shows risk also increased when drug, especially at higher doses, is used with certain drugs.

Related Posts:

1. Senate Report Questions Avandia
2. Paging Loudspeakers Recalled By TOA Electronics Due to Risk of Impact Injury
3. GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer
4. Proton Pump Inhibitors (PPI): Class Labeling Change
5. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review